Emerging science on benefits of whole grain oat and barley and their soluble dietary fibers for heart health, glycemic response, and gut microbiota
Ascendis is expecting sales of Skytrofa to reach up to 240 million this year, and saw just over 5 million in Yorvipath turnover in the second quarter from initial launches in Germany and Austria
Semaglutide vs tirzepatide at 20 units Tirzepatide is a dual GIP/GLP-1 receptor agonist that uses different concentrations and dosing protocols than semaglutide
Obesity and being overweight are characterised by an excessive accumulation of fat in the body, leading to a range of health complications
But now, the narrative is shifting to real-world human outcomes, and this latest study could fuel deeper investigations , long-term cohort studies , and possibly regulatory changes
How tirzepatida and semaglutide work - Photo: Arte/g1 - AREA OF ACTION: It acts on a pair of incretin hormones, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)1